Nagesh Kalakonda News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The combination of tafasitamab and lenalidomide followed by tafasitamab maintenance prolonged responses in patients with relapsed/refractory diffuse large B-cell lymphoma.

United kingdomHospira incyteNagesh kalakondaSpeaker bureauUniversity of liverpoolInternational prognostic indexAnn arborTafasitamab and lenalidomide followed by maintenancePatients with relapsed refractory diffuse largeb cell lymphomaL mind trialThe university of liverpool